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Abstract
Stereotactic body radiation therapy is a well-tolerated modality for the treatment of primary and metastatic liver lesions, and fiducials
are often used as surrogates for tumor tracking during treatment.We evaluated respiratory-induced liver deformation by measuring
the rigidity of the fiducial configuration during the breathing cycle. Seventeen patients,with 18distinct treatment courses,were treated
with stereotactic body radiosurgery usingmultiple fiducials. Liver deformationwas empirically quantified bymeasuring the intrafiducial
distances at different phases of respiration. Data points were collected at the 0%, 50%, and 100% inspiration points, and the distance
between each pair of fiducials was measured at the 3 phases. The rigid body error was calculated as the maximum difference in the
intrafiducial distances. Liver disease was calculated with Child-Pugh score using laboratory values within 3 months of initiation of
treatment. A peripheral fiducial was defined as within 1.5 cm of the liver edge, and all other fiducials were classified as central. For 5
patients with only peripheral fiducials, the fiducial configuration had more deformation (average maximum rigid body error 7.11 mm,
range: 1.89-11.35mm) when compared to patients with both central and peripheral and central fiducials only (average maximum rigid
bodyerror 3.36mm, range: 0.5-9.09mm, P¼ .037). The largest rigid bodyerrors (11.3 and10.6mm)were in2patientswithChild-Pugh
class A liver disease and multiple peripheral fiducials. The liver experiences internal deformation, and the fiducial configuration should
not be assumed to act as a static structure. We observed greater deformation at the periphery than at the center of the liver. In our
small data set, wewere not able to identify cirrhosis, which is associatedwith greater rigidity of the liver, as predictive for deformation.
Treatment planning based only on fiducial localization must take potential intraorgan deformation into account.
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Introduction
Stereotactic body radiation treatment is a well-tolerated con-
formal modality for the treatment of both primary and meta-
static liver lesions. However, with highly conformal high-dose
treatment, accurately targeting the lesion during free-breathing
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treatment poses important clinical and technical considera-
tions. One method to account for respiration-induced tumor
motion is to place gold fiducials within the liver to dynamically
track the lesion during treatment.1 Due to potential morbidity,
such as tumor hemorrhage or seeding along the implantation
track, fiducials are often placed adjacent to and not directly
inside the target tumor. Sometimes, due to these logistical
complications, a single fiducial may be used even in the pres-
ence of multiple target lesions.
Fiducial placement external to the tumor target is used to
guide radiation targeting, assuming that the configuration of the
fiducial relative to the tumor moves as a rigid body, without
internal deformation, and that the distance from the tumor to the
fiducial will remain constant. Multiple prior reports have quan-
tified the craniocaudal movement of the liver within the abdom-
inal cavity, which has been reported as up to 5.5 cm during
maximum ventilation and 2.5 cm during normal ventilation.2,3
Cardiac-induced motion of the liver has also been described and
is mainly found in the area underneath the heart and therefore
affects a relatively smaller portion of the liver. Maximum dis-
placement of the healthy liver secondary to cardiac-induced
motion ranges from 3 to 5 mm.4 In a recent study, Xu et al
evaluated rigid and nonrigid motion of liver lesions using intra-
treatment locations of the fiducial markers reconstructed from
2-dimensional (2-D) orthogonal images.5 Using orthogonal
X-ray data collected from a robotic stereotactic tracking system,
they were able to characterize relative volume shifts as treatment
progressed due to radiation-induced edema at the target. They
also found that there were small intrafractional fiducial displace-
ments due to deformation, although they did not focus on the
influence that inherent liver characteristics or fiducial location
impart on intrafiducial deformation. Park et al investigated the
motion characteristics of the liver by extracting the coordinates
of 3 fiducial markers from the X-ray projections of the cone
beam computed tomography (CBCT) scans.6 They observed a
large variation in liver motion both interfractionally and intra-
fractionally, as well as the presence of deformation within
different locations of the liver. Finally, Rohlfing et al created
a 4-dimensional (4-D) model of the liver using healthy volun-
teers to biomechanically examine rigid and nonrigid transforma-
tion of the liver. They observed that nonrigid transformation, or
deformation, of up to 34 mm can occur, indicating that the
expected location of a liver region was more than 3 cm away
from where it was predicted to be with rigid deformation.7
Understanding the factors influencing internal deformation
of the liver is particularly important for defining the target
volumes in image-guided liver stereotactic body radiation ther-
apy (SBRT). Currently, there are no guidelines on how to
expand planning target margins, if fiducials are placed nearby
and not directly within the tumor. Using the same margins for
different fiducial-to-tumor distances assumes implicitly that
the fiducial-liver configuration is static. Our purpose was to
quantify the intraorgan deformation of a configuration com-
prised of multiple fiducials. In an exploratory analysis, defor-
mation was categorized as a function of liver disease (healthy
vs cirrhotic) and fiducial location (central vs peripheral).
Materials and Methods
Seventeen patients, with 18 distinct SBRT courses delivered
between 2011 and 2016 in the Department of Radiation Oncol-
ogy at the University of California, San Francisco, were
included in the study. One patient had an additional treatment
course that required new fiducials and a separate plan.
All individuals included in this study gave informed consent
for treatment, and retrospective record review for research pur-
poses was approved by the institutional review board of the
University of California. These patients all had multiple gold
fiducials2-4 implanted within the liver to guide dynamic track-
ing during treatment. The fiducials were placed in or near the
target liver lesion by the interventional radiologist implanting
the gold fiducial; degree of proximity to the lesion was
achieved based on what was deemed to be a safe approach for
placement. The implantation procedure was performed at least
1 week prior to the simulation to allow time for fiducial settle-
ment, thereby minimizing the occurrence of fiducial migration.
During the simulation, an 8-phase 4-D computed tomography
(4-DCT) scan was obtained to evaluate target motion charac-
teristics. All patients were treated on a robotic stereotactic
treatment system (CyberKnife robotic radiosurgery system;
Accuray Inc, Sunnyvale, California) using 6 MV X-rays and
dynamically imaged fiducial tracking.8 Real-time tumor
motion tracking on the CyberKnife system is based on a corre-
lation model between the position of the internal fiducial
(extracted from 2-D orthogonal images) and the position of
external surrogate markers (3 light-emitting diodes [LED]
placed on the patient’s chest prior to each treatment session,
whose position is read out by an infrared camera). Prior to
turning the beam on, the correlation model is created by fitting
the 3-dimensional (3-D) coordinates of the fiducials with the
corresponding time-stamped LED coordinates. During treat-
ments, new X-ray images are acquired every 60 to 120 seconds
and are used to update the model. Based on the model, the robot
is redirected in real time to the anticipated target location so
that radiation delivery is always synchronized to the continu-
ously changing target position.
Patients were treated with doses of 1250 to 5400 cGy over 3
to 5 fractions based on the size of the liver lesion and extent of
the underlying liver disease. Patients had between 1 and 4
intrahepatic lesions treated. The extent of liver disease was
calculated using the Child-Pugh score for cirrhosis mortality
based on laboratory values drawn within 3 months of initiation
of treatment. In this study, Child-Pugh score was used as a
surrogate for liver stiffness, which may impact organ
deformation.
The 4-DCT was imported into an image management soft-
ware (MIM; MIM Software Inc, Cleveland, Ohio). Point con-
tours were placed at the center of each fiducial on the axial,
coronal, and sagittal plane, and the 3-D coordinates of the
fiducial were recorded. These points were used as a reference
point from which the intrafiducial distance was calculated.
Data points were collected at the 0%, 50%, and 100% inspira-
tion phases of the respiratory cycle. These 3 sets of data points
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were selected as they represented the smallest and largest
excursions of the fiducial during the respiratory cycle. The
distance between each pair of fiducials (dij) was measured at
each phase (Figure 1).
Differences in dij between phases were calculated and used
to quantify deformation in the fiducial configuration during
respiration. The maximum rigid body error (RBEmax) was cal-
culated as the largest difference in the intrafiducial distances
between the 2 respiratory phases:
RBEmax ¼ maxðjd0ij  d50ij j; jd0ij  d100ij j; jd50ij  d100ij jÞ:
The mean rigid body error (RBEmean) was calculated as the
average difference in the intrafiducial distances between the 2
respiratory phases:
RBEmean
¼ meanjd
0
ij  d50ij j þmeanjd0ij  d100ij j þ meanjd50ij  d100ij j
3
 !
:
For each pair of fiducials (i, j), the average deformation was
defined as the average difference in intrafiducial distances over
the 3 respiratory phases:
Average deformation ¼ jd
0
ij  d50ij j þ jd0ij  d100ij j þ jd50ij  d100ij j
3
 !
:
We used a threshold of 2 mm as a cutoff to define the
occurrence of clinically significant deformation. For treatments
conducted with dynamic fiducial tracking, the dynamic fiducial
rigid body error (RBECK) is defined as the maximum difference
in the intrafiducial distances between the digitally recon-
structed radiograph (DRR) and the X-ray images obtained dur-
ing treatment:
RBECK ¼ maxðjdDRR12  dXray12 j; jdDRR23  dXray23 j;
jdDRR13  dXray13 jÞ:
For robotic stereotactic treatments at our institution, the
error threshold is set to 2 to 2.5 mm. Depending on target
margins and other clinical consideration, the RBECK threshold
is set to be more or less stringent. Murphy9 calculated the
fiducial-based tracking accuracy as a function of perturbation
of the fiducial configuration, and their data can be used to
select the RBE threshold. If the tracking error is above this
threshold, an interlock results and the treatment is paused. For
this analysis, a cutoff was set at 2 mm to define a clinically
significant deformation.
A peripheral lesion was defined by a location within 1.5 cm
of the liver edge, and all other lesions were characterized as
central lesions. The 1.5 cm cutoff was determined by measur-
ing the closest distance from the center of each fiducial to the
liver capsule; the median of those values was 1.5 cm. Values
equal to or less than 1.5 cm from the liver edge defined
peripheral fiducials, and values greater than 1.5 cm defined
central fiducials.
Results
Eleven patients had primary hepatocellular carcinoma (HCC)
and 6 had metastatic disease. For metastatic tumors, the pri-
mary disease histologies included colorectal carcinoma, eso-
phageal carcinoma, breast adenocarcinoma, and base of tongue
squamous cell carcinoma. Ten patients had Child-Pugh class A
liver disease, 4 had class B, 3 had class C, and 1 had insuffi-
cient laboratory data for calculation (metastatic breast cancer).
Five patients had centrally located fiducials, 5 had peripheral
fiducials, and 8 had both peripheral and central fiducials. For a
complete description of patient characteristics and rigid body
error results, see Table 1.
For 5 patients with only peripherally located fiducials, the
average RBEmax was 7.11 mm (range: 1.89-11.35 mm), and for
those with peripheral and central or only centrally located fidu-
cials, the average RBEmax was 3.36 mm (range: range: 0.5-9.09
mm), which did represent a significant difference in deforma-
tion (P ¼ .037). The RBEmax and RBEmean for all patients are
presented in Table 2 for peripheral fiducials only and central/
peripheral and central fiducials. Although there was a signifi-
cant difference in the deformation, with only 5 patients in the
peripheral-only fiducial cohort, we recognize that our study is
limited by its small size. The largest excursions were 11.3 mm
(Figure 2) and 10.6 mm, both found in patients with only per-
ipheral fiducials. In the patient in Figure 2, the very large
deformation (11.3 mm) between the 0% and the 100% phase
was attributable to compression of the liver due to increased
thoracoabdominal pressure in maximal respiration.
Across all of the patients, for each fiducial pair, we exam-
ined the potential correlation of intrafiducial distance with
absolute deformation averaged among the 3 respiratory phases
(Figure 3). Although the largest deformation (10.6 mm) was
observed for an intrafiducial separation of 10.1 cm (peripher-
ally located fiducials), the data showed a poor linear correlation
(R2 ¼ .019), indicating that the location of the fiducials was
more important than the distance between them. The lack of
correlation between intrafiducial distance and average defor-
mation could have also been influenced by the limited number
of patients.
Figure 1. Rigid body error calculation. Data points were collected at
the 0%, 50%, and 100% inspiration phases of the respiratory cycle,
and the distance between each pair of fiducials (dij) was measured at
each phase. Differences in dij between phases were used to quantify
deformation in the fiducial configuration during respiration.
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We did not find an overall association between deformation
and liver function at the time of radiation treatment (P ¼ 0.88).
Patients with Child-Pugh class A disease had an average
RBEmax of 4.6 mm (range 0.5-11.3 mm) and patients with
class B and C disease had an average RBEmax of 4.3 mm
(range 0.5-8.7 mm) (Figure 4).
Discussion
While the impact on the liver due to respiratory and cardiac
motion has been described previously, our study describes the
potential limitation of radiation treatment planning using fidu-
cial tracking alone given the extent of intraorgan deformation
of the liver inferred from the position of surrogate fiducials
Table 1. Patient Characteristics.
Patient ID
Number of
Liver Lesions
Number of
Fiducials Fiducial Location Type of Lesion Child-Pugh Class
1 1 3 Central Colorectal A
2 1 3 Central HCC A
3 1 3 Peripheral (1), central (2), peripheral (3) HCC A
4 1 3 Central HCC C
5 2 3 Central HCC C
6 2 3 Central (1,3), peripheral (2) HCC A
7 2 2 Peripheral Base of tongue A
8 3 2 Peripheral Breast Undetermined
9 4 4 Peripheral HCC A
10 2 2 Peripheral (1), central (2) HCC B
11 1 2 Central (1), peripheral (2) HCC C
12 2 2 Peripheral HCC B
13 4 4 Peripheral HCC B
14 3 3 Peripheral (1), central (2,3) HCC B
15 3 3 Peripheral (1) central (2) Colorectal A
16 1 2 Central Colorectal A
17 1 3 Peripheral (1,3 ), central (2) Esophageal A
18a 2 4 Central (1, 2) peripheral (3, 4) Base of tongue A
Abbreviations: HCC, hepatocellular carcinoma; SBRT, stereotactic body radiation therapy.
aPatient 18 had additional metastatic disease noted in the liver and was treated with a second course of SBRT after additional fiducials were placed.
Table 2. RBEmax and RBEmean for Peripheral Fiducials and for
Central and Peripheral/Central Fiducials.
Patient ID Fiducial Location
Max
RBE
Mean
RBE
Peripheral fiducials
7 Peripheral 11.3 7.6
8 Peripheral 3.1 2.0
9 Peripheral 10.6 3.4
12 Peripheral 1.9 1.3
13 Peripheral 8.7 1.7
Average RBE 7.11 3.2
Central and peripheral/central fiducials
1 Central 1.6 0.4
2 Central 1.8 0.9
3 Peripheral (1), central (2),
peripheral (3)
4.5 2.6
4 Central 4.0 2.6
5 Central 5.2 3.5
6 Central (1, 3) peripheral (2) 1.9 0.8
10 Peripheral (1), central (2) 2.5 1.7
11 Central (1), peripheral (2) 0.5 0.3
14 Peripheral (1), central (2, 3) 7.3 2.9
15 Peripheral (1), central (2) 3.0 2.0
16 Central 0.5 0.3
17 Peripheral (1, 3), central (2) 9.1 4.3
18a Central (1, 2), peripheral (3, 4) 1.5 0.4
Average RBE 3.36 1.75
Abbreviations: RBE, rigid body error; RBEmax, maximum rigid body error;
RBEmean, mean rigid body error.
aPatient 18 had additional metastatic disease noted in the liver and was
treated with a second course of SBRT after additional fiducials were
placed.
Figure 2. Four-dimensional computed tomography (4-DCT) demon-
strating greatest fiducial excursion during respiration. Sagittal view
from 0%, 50%, and 100% inspiration phases of the 4-DCT in a patient
with liver metastases. Intrafiducial distance at the 0% phase is 5.7 cm,
at 50% inspiration is 5.2 cm, and at 100% is 4.6 cm. Rigid body error
calculated using the relative position of the 2 fiducials for the 0% to
50% phase is 2.6 mm, for the 0% to 100% phase is 11.3 mm, and for
the 50% to 100% phase is 8.7 mm.
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extracted from 4-DCT data. Original to our study is also the
characterization of deformation as a function of fiducial
location and disease status. Intraorgan deformation appears
to be more pronounced along the periphery of the organ,
while the central portion of the liver remains more rigid.
This is due to the proximity of the peripheral edges of the
liver to other intraabdominal and intrathoracic organs that
physically compress the periphery of the liver and enact
effects on local circulatory mechanics. Although the excur-
sions of the liver throughout the respiratory cycle are easily
visible on imaging, localized forms of intraorgan deforma-
tion secondary to cardiac movement, intrahepatic blood
flow, and gastrointestinal peristalsis are more difficult to
visualize and quantify.
In a study analyzing data collected from a robotic stereo-
tactic tracking system, Xu et al calculated proportional volume
changes throughout treatment and rotational displacement of
each fiducial relative to its mean position.5 They were able to
find that compared to the first fraction, the second and third
fractions exhibited increased volumes, which could be due to
radiation-induced edema. Treatment-related edema could cer-
tainly enact greater fiducial displacement as treatment pro-
gresses, especially given that stereotactic radiotherapy
delivers larger fractional doses and can result in more peritu-
moral edema.10 Xu et al found mean intrafractional shifts of
2.1, 2.9, and 6.4 mm in the x, y, and z planes, respectively, and
mean rotational angle variations were 1.2, 1.8, and 1.7 in the
roll, pitch, and yaw angles, respectively. The greatest displace-
ments were seen in the superior–inferior direction and the
smallest in the left–right direction. Additionally, Bertholet et
al recently described a superior–inferior fiducial marker trans-
lation of up to 9.2 mm, a mean rotational range of 2.9 to 4.0
around all axes and rotation up to 28.6 in a single CBCT
scan.11 Although the methods used for data collection and
measurement were very different from ours, with a focus on
intrafractional changes rather than intrinsic temporal deforma-
tion, these data support our overall conclusion that the liver
does experience multiple vectors of deformation and treatment
planning processes would ideally not depend on it being an
internally nondeforming organ.
In a separate study, we evaluated respiratory-induced liver
rotations and their corresponding dosimetric impact.12 We
separately coregistered the planning CT with 4 phases of the
4-DCT scan by (1) rigid registration of the spine and (2) rigid
registration of the 3 fiducials. For each registration, rotational
and translational vectors as well as dosimetric parameters were
calculated. We concluded that liver rotation had a significant
impact on the dose delivered to the nearby critical structures
with dose differences of 1.63, 0.5, 2.29, and 1.6 Gy on average
in the maximum dose to duodenum, stomach, bowel, and eso-
phagus, respectively.12 This separate work confirms that
motions of the liver during radiotherapy could have a mean-
ingful clinical impact on nearby structures.
Other previous studies have shown that geometric uncer-
tainty due to deformation and breathing variations can lead to
significant deviation in the accumulated delivered dose relative
to the planned dose distribution or even the dose distribution
predicted using 4-DCT.13 Deviation from the planned dose due
to organ deformations can lead to exceeding the planned dose
for normal tissues, particularly the bowel, which lies directly
adjacent to the liver and is frequently dosed to near-maximal
tolerance.13 Marginal misses or underdosing of the target tumor
could also occur if target motion is not synchronous with fidu-
cial motions and tracking accuracy is compromised due to
deformations in the fiducial configuration. As discussed earlier,
this is of clinical relevance, as the fiducial is often placed near,
but not within, the target, and stereotactic treatment planning
margins can be very tight, especially in the periphery in adja-
cency to critical organs but also where intrafiducial displace-
ments are the largest. Adjustment of planning target volume
(PTV) margins requires patient-specific analysis to offset the
uncertainty related to these intrafiducial deformations. We con-
clude from our study that intrafiducial deformation should be
Figure 3. For each fiducial pair, we examined the potential correlation
of intrafiducial distance with absolute deformation averaged among
the 3 respiratory phases. Poor linear correlation (R2 ¼ .019) indicates
that the location of the fiducials was more important than the distance
between them.
Figure 4.We examined the potential association between deformation
and liver stiffness as characterized by Child-Pugh class. Poor linear
correlation (R2 ¼ .019) was found, indicating a lack of association in
this data set.
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of particular concern when targeting tumors lying within 1.5
cm of the periphery of the liver. As a preventive measure, at
institutions that utilize fiducial tracking, it would be useful to
develop internal guidelines for fiducial placement emphasizing
implantation toward the central aspects of the liver, where
deformation will be less, or at least to attempt to avoid place-
ment within 1.5 cm of the periphery when possible.
In an exploratory analysis, we were unable to find a
correlation between the degree of cirrhotic liver disease and
intrafiducial deformation. Although Child-Pugh score was
not developed as a score of liver fibrosis or stiffness, mul-
tiple prior studies, including Recio et al, have documented
that liver stiffness correlates with Child-Pugh score in
patients with cirrhosis and that with progressive cirrhosis
there is less deformation of the liver.14 Furthermore, recent
magnetic resonance imaging and ultrasound studies have shown
that with progressive cirrhosis, the deformation of the liver is less
pronounced.4,15 However, within our small study, we could not
confirm these hypotheses. Additionally, although the majority of
patients who have HCC have underlying cirrhosis, noncirrhotic
HCC can occur, and therefore we could not assume that the
patients with HCC in our study had cirrhotic livers. Hepatocellu-
lar carcinoma is frequently a diagnosis made on imaging, and
histopathology documenting HCC or cirrhosis was absent in
many of our patients. Nonetheless, we believe that intrafiducial
deformation in patients with differing degrees of liver stiffness
due to disease may be an area for further investigation.
One important limitation of this study, due to the nature of
the data acquisition, was the inability to evaluate inter- or
intrafraction motion of the entire fiducial configuration, as only
the relative position of the fiducials used for tracking was
recorded. CyberKnife patients are not aligned based on a treat-
ment isocenter and do not have in-room volumetric imaging
from which this information would be extracted.
In this study, we show that peripherally located fiducials
within the liver were more subject to intraorgan deformation.
We did find a significant difference between groups even with
a small number of patients in this study, but further validation
would be confirmatory. Although we believe that patient-
specific deformation should be considered as a factor in PTV
margin adjustment, additional studies would provide more
capacity to create robust deformation models and better quan-
tify recommended margin expansions. Gating according to a
specific phase of the respiratory cycle would be a potential
solution, if this technology were used in conjunction with con-
firmation of the reproducibility of the fiducial configuration in
the treatment phase, as assessed on 4-DCT.6,16 In patients who
are to have multiple lesions treated without gating (for instance,
on CyberKnife), we recommend the creation of a separate
treatment plan for each distinct lesion, as the relative position
of the tumors within the liver does not remain constant during
the breathing cycle. Dose accumulation may be used to com-
bine these separate treatment plans to obtain the dose–volume
histogram for the liver as a whole. Furthermore, in this sce-
nario, when medically possible, the implantation of multiple
fiducials, each immediately adjacent to or in close proximity to
each lesion, is recommended, such that the deformations of the
fiducial-to-tumor distance can be minimized.
Conclusion
The liver frequently experiences intraorgan deformation, and a
configuration of multiple fiducials does not act as an internally
static structure. In this study, we observed the greatest defor-
mation at the periphery within 1.5 cm of the liver edge, which
has important clinical implications for location-specific planning
margin adjustment. This finding holds particular relevance for
lesions at the inferior liver edge, which often abut bowel, and
where unanticipated deformation may place the bowel in a high-
dose region. Further studies are planned to define population-
based margins based on lesion location and the distance of the
tumor target from the fiducial used for tracking.
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